Guideline on HER2 Testing for Patients with Gastric Cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE COLLEGE OF AMERICAN PATHOLOGISTS, the American Society for Clinical Pathology, and the American Society of Clinical Oncology released an evidence-based clinical practice guideline on human epidermal growth factor receptor 2 (HER2) testing for patients with gastroesophageal cancers. The guideline provides recommendations about appropriate HER2 testing for patients at key decision points throughout their cancer...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login